New Perfinity Integrated Digestion Platform Simplifies Protein Sample Preparation

COLUMBIA, Md., JULY 9, 2012 — In partnership with Perfinity Biosciences, Shimadzu Scientific Instruments has released the Perfinity Integrated Digestion Platform (IDP). Based on the Perfinity Workstation, the Perfinity IDP system automates key proteomics workflow steps to significantly reduce sample preparation times and enhance reproducibility.

Traditionally, manual sample preparation techniques involving 18-hour tryptic digestion to reverse-phase HPLC and mass spec detection take three days to complete. With Perfinity IDP, which features a customized Shimadzu HPLC system and multiple Perfinity columns, this time is reduced dramatically to 30 minutes or less. This is accomplished through automated integration of buffer exchange, digestion, desalting and reverse-phase separation. The automated process removes much of the equipment and labor associated with LCMS analyses of proteins, minimizing a potential source of error and improving laboratory productivity.

In addition to the substantial time savings, Perfinity IDP provides users with consistent, highly reproducible results. In contrast to manual techniques, in which samples are prone to sample loss and contamination, the integration of hardware components, columns, buffers and software eliminates disjointed protein sample prep processes. As a result, coefficient of variation values reported at each step, as well as for the entire assay, are less than 10 percent.

Perfinity IDP can be used in multiple application areas, including assay development, protein purification, drug development and biomarker discovery. The modular nature of the system enables upgrading to the full Perfinity Workstation, which features a second column oven and automation of affinity selection.

For more information about Perfinity IDP, visit http://www.ssi.shimadzu.com/products/product.cfm?product=perfinityworkstation.

About Shimadzu Scientific Instruments Inc.

Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corp., headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $3 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/Industrial and Analytical Instruments. In the United States, SSI has a network of more than 50 locations providing local and regional sales, service and technical support. Visit www.ssi.shimadzu.com for more information.

About Perfinity Biosciences Inc.

Perfinity Biosciences, Inc. is a life science technology company committed to providing our customers with innovative solutions that reduce the time and labor requirements associated with protein separations and mass spec sample preparation. Visit www.perfinity.com for more information.

More News

  • Researchers Propose New Regulations for Food Packaging Chemicals

    Scientists have proposed a new way to prioritize regulatory review of the more than 15,000 chemicals used in food packaging and other food contact materials, most of which currently lack the safety data needed to protect consumers. read more
  • Brain Activity Mirrors the Shape of Each Breath

    Each individual breath—not just breathing rate—is closely linked to the pattern of electrical activity in brain regions tied to cognition, emotion and memory, according to a new study that could help explain how breathing disorders turn deadly. read more
  • Body's Organs Age in Distinct, Synchronized Waves

    The human body doesn't age at a single, steady pace. Instead, each organ follows its own timeline, and organs that age quickly tend to have "aging partners" that speed up in sync, according to a new study that mapped structural aging across 40 types of tissue. read more